Risk-sharing in the Pharmaceutical Industry The Case of Out-licensing /

The costs of developing a new drug have reached record levels in the pharmaceutical industry. As any failure of a new drug candidate can lead to significant losses, many pharmaceutical companies are looking for new approaches to reduce their exposure to R&D risks. In this context, the book deals...

Full description

Bibliographic Details
Main Author: Reepmeyer, Gerrit (Author)
Corporate Author: SpringerLink (Online service)
Format: Electronic eBook
Language:English
Published: Heidelberg : Physica-Verlag HD, 2006.
Series:Contributions to Management Science,
Subjects:
Online Access:Full Text via HEAL-Link
Table of Contents:
  • Key Issues in Managing Pharmaceutical Innovation
  • Risk-sharing as New Paradigm in Pharma R&D Collaborations
  • Case Studies on Risk-sharing in Pharma R&D Collaborations
  • Characteristics of Risk-sharing in Pharma R&D Collaborations
  • Theoretical Basis for Risk-sharing in Pharma R&D Collaborations
  • Managerial Recommendations for Risk-sharing in Pharma R&D Collaborations
  • Conclusion.